Death Be Not Proud: PhiPhiLux from OncoImmunin Inc. Offers New Insights into Apoptosis

Time-lapsed confocla microscopic images of T-cells undergoing apoptosis. The green fluroescence (a cyanine dye, which indicates a mitochondrial membrane potential) marks healthy cells, while the red fluorescence is derived from PhipPhiLux cleavage in apoptotic cells. Time-of-death determinations are not just a challenge for coroners. Researchers in the field of apoptosis are constantly striving for ways to detect the onset of cell death earlier and with greater specificity to bring them closer

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Time-lapsed confocla microscopic images of T-cells undergoing apoptosis. The green fluroescence (a cyanine dye, which indicates a mitochondrial membrane potential) marks healthy cells, while the red fluorescence is derived from PhipPhiLux cleavage in apoptotic cells. Time-of-death determinations are not just a challenge for coroners. Researchers in the field of apoptosis are constantly striving for ways to detect the onset of cell death earlier and with greater specificity to bring them closer to the true cause of cell death. Now a small company in College Park, Maryland, OncoImmunin Inc., has provided just the tool apopoticians have been seeking. Specializing in peptide-based diagnostics for cancer and infectious diseases, this company has designed a new class of fluorogenic protease substrates that gives the earliest determinations of the onset of cell death to date. PhiPhiLux, short for fluorescent-fluorescent light, incorporates the prototypical caspase-3-recognition sequence DEVD into a bifluorophore-derivitized peptide, which mimics the structural loop ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies